Regulating autologous stem cell interventions in Australia: updated review of the direct-to-consumer advertising restrictions

ConclusionsThe polycentric legal regime regulating biologicals in Australia clearly makes DTC advertising of ASCIs unlawful. Health practitioners who promote ASCIs, either online, in print or in other media forms, may be penalised in different ways and by different authorities.What is known about the topic?Although several analyses have examined the regulation of ASCIs in Australia, no analysis has studied the reforms made in 2018 relating to the advertising of biologicals. As such, this analysis contributes a fresh examination of these relatively recent reforms.What does this paper add?This analysis clarifies the effects of these new advertising regulations, providing clear guidance on the relevant legal provisions for the benefit of health practitioners and health professionals more generally.What are the implications for practitioners?Health practitioners, especially those who offer ASCIs, should be aware that civil and criminal penalties are likely to be imposed on individuals who promote biologicals in Australia by any means.PMID:33952390 | DOI:10.1071/AH20217
Source: Australian Health Review - Category: Hospital Management Authors: Source Type: research